Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A

M Franchini, D Girelli, O Olivieri, G Castaman, G Lippi, G Poli, GL Salvagno, G Tagariello, A Giuffrida, M De Gironcoli, M Morfini, Erik Berntorp, G Gandini

Research output: Contribution to journalArticlepeer-review

17 Citations (SciVal)

Abstract

We report the case of a patient with mild haemophilia A, due to a Tyr2105Cys mutation in exon 22 of the C1 domain, who developed a high-titre factor VIII inhibitor (maximum titre 1600 BU) with recurrent severe haemorrhages and fatal intracranial bleeding. Based on published data, it appears that although this mutation occurs rarely in patients with mild or moderate haemophilia A, it is frequently associated with the development of high-titre inhibitors.
Original languageEnglish
Pages (from-to)448-451
JournalHaemophilia
Volume12
Issue number4
DOIs
Publication statusPublished - 2006

Subject classification (UKÄ)

  • Hematology

Keywords

  • mild haemophilia A
  • bleeding
  • inhibitors

Fingerprint

Dive into the research topics of 'Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A'. Together they form a unique fingerprint.

Cite this